Jason Cornelius, MD
Neurology · Maple Grove, MNNPI 1982610739
Payments from drug & device makers
Across 31 payments — averaging $1381.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$43K
- Jazz Pharmaceuticals Inc.$49
- Philips North America LLC$48
- GE HealthCare$16
- Novartis$15
- Lilly USA, LLC$14
- plus $14 from 1 others
What the payments were for
- Consulting fees$11,36393%
- Speaking & faculty fees$1501%
- Food & beverage$6475%
- Gifts$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 22 | $42,684 |
| Jazz Pharmaceuticals Inc. | 3 | $49 |
| Philips North America LLC | 2 | $48 |
| GE HealthCare | 1 | $16 |
| Novartis | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Resmed Corp | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$9,628
- Inspire$2,075
How this compares
$42,840 in reported general payments places this provider in the 80th percentile of 434 neurology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 20 | $278,666 |
| NeuproRotigotine | 30 | $46,784 |
| HorizantGabapentin Enacarbil | 11 | $26,352 |
| XcopriCenobamate | 14 | $16,357 |
| Doxepin Hcl | 154 | $13,708 |
| BelsomraSuvorexant | 15 | $7,042 |
| Lacosamide | 30 | $7,009 |
| Gabapentin | 187 | $3,027 |
| Levetiracetam | 50 | $2,385 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 19 | $2,024 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 127 | $1,869 |
| Armodafinil | 22 | $1,365 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 53 | $1,255 |
| Ramelteon | 12 | $1,066 |
| Zolpidem Tartrate ErZolpidem Tartrate | 40 | $851 |
Paid to pharmacies, not to this prescriber.
Other neurology in Maple Grove
- Jonathan CalkwoodGolden Valley$4.9M
- Jessica StulcGolden Valley$3.3M
- Sean PittockRochester$3.2M
- Miguel Paz SoldanRochester$2.4M
- Ryan TownleyRochester$2M
- Rajiv AggarwalBurnsville$1.9M
- Eoin FlanaganRochester$1.7M
- David KnopmanRochester$1.6M
- Jeffery AllenMinneapolis$1.5M
- Christopher StreibMinneapolis$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.